| Autor: |
M. M. Davydov, P. A. Zeynalova, A. A. Fedenko, D. A. Chekiny, E. K. Ibragimov, A. A. Filimonov, O. V. Sinitsyna, E. A. Bogush, M. A. Chekalova, G. F. Allakhverdieva, M. V. Shamanova, I. V. Zhguleva, V. Yu. Kirsanov, V. E. Ponomarev, S. B. Polikarpova, T. T. Valiev, M. A. Kurtser |
| Rok vydání: |
2021 |
| Předmět: |
|
| Zdroj: |
MD-Onco. 1:38-42 |
| ISSN: |
2782-3202 |
| Popis: |
Per the majority of authors, melanoma is the most common tumor diagnosed during pregnancy (31 % of all malignant neoplasms). In approximately 1/3 of women melanoma developed in child-bearing age is diagnosed during pregnancy or in the postpartum period. However, only some retrospective studies analyzed the effect of pregnancy on melanoma development, and conclusive data on development, progression and treatment of BRAF-mutant melanoma is lacking. In this subpopulation of patients, BRAF status supposedly can negatively affect disease outcome irrespective of treatment methods.The article presents a clinical case of recurrence of melanoma with the BRAF V600E mutation during pregnancy. The patient underwent lymph node dissection during pregnancy prolongation, after labor she received antitumor drug therapy with МЕК and ВRAF inhibitors. Melanoma recurrence during pregnancy did not worsen treatment outcomes for the mother and embryo. |
| Databáze: |
OpenAIRE |
| Externí odkaz: |
|
